Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natroba PK and Safety in Pediatric Scabies
NCT05310734Phase 4Recruiting
- Sponsor
- Cipher Pharmaceuticals
- Start
- Mar 2022
- Primary completion
- Nov 2025
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of spinosad in scabies, sponsored by Cipher Pharmaceuticals. Started Mar 2022; status: recruiting.
02
Drugs
spinosad
03
Conditions
scabies
Beyond the preview
Go deeper on NCT05310734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05310734.